Prescription Justice’s president, Gabriel Levitt, organized a dynamic panel session to discuss the importance of online access to safe and affordable medicines at the RightsCon conference last month in Brussels, Belgium. Created and organized by Access Now, since 2011, RightsCon has become one of the world’s leading events covering the implications of the Internet on society. This past conference, it’s largest ever, brought together 1500 people from 100 countries, including human rights experts and activists, business leaders, technologists, engineers, investors, activists and government representatives; most who are there to promote an open Internet and digital rights globally. (more…)
The U.S. Centers for Disease Control and Prevention (CDC) - Public Health Grand Rounds – recently hosted a webinar on “Overcoming Barriers to Medication Adherence for Chronic Diseases.”The event brought together a panel of leaders in pharmacy, nursing, medicine, academia, and public health to discuss the burden of medication nonadherence and barriers for adherence among patients with chronic diseases—including HIV/AIDS.
Medication nonadherence manifests in two distinct behaviors: intentional, such as choosing to forgo filling a prescription because of cost, or unintentional, where patients simply forget to take their medication or are unable to manage multiple medications or complex treatment regimens. The panelists highlighted how intervention strategies aimed at medication adherence can positively affect patient health outcomes. (more…)
Morning Consult, a nonpartisan digital media and research company, has published an op-ed, The RX Rip-off, by Prescription Justice’s Executive Director, Jodi Dart. The op-ed highlights Prescription Justice’s recent poll by Zogby analytics that reveals roughly 79 percent of Americans believe prescription drug prices are too high, and nearly 52 percent believe that pharmaceutical companies engage in price gouging and put profits over patients. The poll also shows that overwhelming majorities support changes that will bring down drug prices, which comes hard on the heels of new Prescription Justice analysis showing 45 million Americans did not fill a prescription last year due to cost.
Ms. Dart writes that there are concrete steps that members of Congress and the Trump administration should take to help the millions of Americans who struggle with the high cost of prescription medications. These include allowing Medicare to negotiate with pharmaceutical manufacturers to lower prices, ending pay to delay to increase access to generic drugs and importing less expensive drugs from other countries, and, finally, making personal drug importation legal. Ms. Dart also emphasizes that President Trump could immediately help Americans through executive actions to expressly permit the safe use of international online pharmacies on which orders are placed to import medication for personal use.
"By introducing the Affordable and Safe Prescription Drug Importation Act, Sens. Sanders, Booker and Casey have heeded the call of the millions of Americans who struggle each year with the insurmountable costs of prescription drugs " said Jodi Dart, executive director of Prescription Justice. "This legislation will provide new safety protocols and guidance for American consumers who need access to lower cost medications from safe international pharmacies, beginning with Canada. Last year, 45 million Americans did not fill a prescription because of costs, and a recent poll commissioned by Prescription Justice shows overwhelming majorities support changes that will bring down drug prices. President Trump and members of Congress have an opportunity to make good on their promises to lower drug prices for American consumers. We hope they will have the political will and courage to pass this important legislation."
Prescription Justice is a non-profit organization that brings together doctors, lawyers, public health advocates, and companies dedicated to helping people afford medication. Prescription Justice advocates for legislative and policy reforms to allow personal prescription importation, permitting Medicare to negotiate drug prices, and ending "pay to delay" activities by pharmaceutical companies that prevent lower cost generics from coming to market.
According to a new Zogby Poll, 75% of Americans agree with President Trump that the pharmaceutical industry is “getting away with murder” on drug prices. While Republican members of Congress have prioritized the dismantling of Obamacare, the majority of Americans, both Republican and Democrats alike, are clearly concerned about prescription drug costs.The poll shows that 79 percent of Americans believe drug prices are too high, while nearly 52 percent believe the pharmaceutical industry is price gouging and putting profits over patients.
There is a clearly a public health crisis. Too many Americans are going without necessary medications because of their skyrocketing costs. This new poll shows the serious effects of exorbitant drug prices on consumers: because of costs, nearly 1 in 3 Americans say they have gone without medication and 1 in 4 have had to choose between medication and a necessity like food or housing.